April 9, 2020
Via: BioSpaceArcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced plans to initiate a human clinical trial this Summer for its COVID-19 […]
February 3, 2023
February 6, 2023
January 9, 2023
February 2, 2023
January 19, 2023
January 17, 2023